Infection following a stereotactic brain biopsy: Myth or reality? Retrospective study between 2009 and 2023
Authors' conclusion
Infectious complications following stereotactic brain biopsy are rare and do not significantly affect morbidity or mortality.
Study context
- Population
- All patients having a stereotactic brain biopsy, 2009–202315-year period
- Participants
- 2,312 patients
- Exposure
- Patients with vs without post-biopsy infection
- Postbiopsy infections (PBI)+n = 11
- Outcome
- Incidence of post-biopsy infections
Methodological detailsmonocentric
- Monocentric
Main finding
As reported in the abstract
Post-biopsy infection incidence
PBI+
0.47%
11
- Predominantly Staphylococcus
- 36%
Observational data: associations, not effects.
Further findings
| Outcome | PBI+days | PBI- | P value |
|---|---|---|---|
| ICU LOSLonger in PBI+ | 21 | — not stated in the abstract | P = 0.01 |
| Hospital LOS | 11 | 1 day | P = 0.01 |
— not stated in the abstract
Demographic or lesion characteristics
- No significant differences between PBI+ and PBI-
Mortality
- No significant difference
Original publication
Infection following a stereotactic brain biopsy: Myth or reality? Retrospective study between 2009 and 2023. Anaesth Crit Care Pain Med. Published 27 September 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →